CWChengbin Wang

Chengbin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chengbin Wang has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Viral Pathogen-Specific Severe Acute Respiratory Infections in Hospitalised Adults in Europe: Epidemiological Findings from the id.DRIVE Study 2024–2025

    by Katherine Newell, Nikki Vroom, Cátia Marques, Ekaterina Maslova, Farid L Khan, Kok-Yew Ngew, Hannah R Volkman, Chengbin Wang, Juan V Hernandez-Villena, Negar Aliabadi, et al.

    Introduction Lower respiratory tract infections represent a major public health burden, but adult data on respiratory viruses except influenza and COVID-19 are limited. Most European surveillance systems report aggregate data lacking patient-level detail. Methods We utilised the multicountry id.DRIVE surveillance study data to describe the epidemiology, clinical characteristics, and outcomes of adults hospitalised with pathogen-specific severe acute respiratory infections (SARI) during 2024–2025. Adults (≥ 18 years) hospitalised with SARI across 17 hospitals in Spain, Italy, and Germany between 1 September 2024 and 31 August 2025 were included. All participants were tested using reverse transcription polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), respiratory syncytial virus (RSV), and influenza A/B (testing additional respiratory pathogens varied by hospital). Descriptive analyses were stratified by pathogen. Results Of 8730 included participants (median age, 77 years), 14.3% (n = 1249) tested positive for influenza A, 6.9% (n = 606) SARS-CoV-2, 6.4% (n = 554) RSV, and 0.8% (n = 74) for influenza B. Positivity peaked for influenza and RSV in December–January, and for SARS-CoV-2 in July. Comorbidity burden was substantial: 51.9% of all SARI participants had ≥ 3 chronic conditions, reaching 62.3% in those with RSV. RSV-positive SARI patients were older (median age, 80 years); oxygen therapy was required in 72.0%, non-invasive ventilation in 12.3%, and in-hospital mortality was 9.4%. Over 75.0% of SARI cases positive for a respiratory virus received antibiotics during hospitalisation. Conclusion Viral pathogens remain a major cause of adult SARI hospitalisations in Europe. Our findings highlight the continued burden and seasonal diversity of viral respiratory pathogens, supporting the value of integrated, pathogen-specific SARI surveillance guiding prevention strategies.


  • Open Access

    Comparison of Hospitalization Costs Associated With Human Metapneumovirus and Respiratory Syncytial Virus Infection in US Adults

    by Bradley K Ackerson, Emily Rayens, Lina S Sy, Hung Fu Tseng, Lei Qian, Yi Luo, Rachelle Juan, Xuan Huang, Jennifer H Ku, Punam P Modha, et al.

    Hospitalization costs on human metapneumovirus (hMPV) are needed to inform healthcare priorities, including vaccine and treatment development. Among 5775 adult hospitalizations with hMPV or respiratory syncytial virus (RSV), hMPV was associated with shorter length of stay but greater frequency of pneumonia, resulting in adjusted mean costs comparable to RSV hospitalization.

  • Open Access

    Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus

    by Emily Rayens, Lina S Sy, Lei Qian, Bradley K Ackerson, Jaejin An, Yi Luo, Xuan Huang, Jennifer H Ku, Punam P Modha, Radha M Bathala, et al.

    Background: Human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) are among the leading causes of acute respiratory infection. We evaluated the risk of severe outcomes in adults hospitalized with hMPV compared to RSV at Kaiser Permanente Southern California. Methods: We performed a retrospective cohort analysis in adults aged ≥18 years who tested positive for hMPV or RSV from 7 days prior to 2 days after the date of hospital admission between 2011 and 2024. Outcomes included length of hospital stay, intensive care unit (ICU) admission, occurrence of complications, readmission, and mortality. Risk ratios (RR) and hazard ratios (HR) were estimated for hMPV compared to RSV hospitalizations. Results: This study included 2859 hMPV-associated and 3029 RSV-associated hospitalizations. Approximately 30% of hMPV and RSV hospitalizations had an extended hospital stay (≥7 days) and about 15% were admitted to the ICU. The risk of an extended hospital stay was lower in hMPV than RSV hospitalizations (RR: 0.91 [95% CI: 0.84–0.99]). Over half of hMPV and RSV hospitalizations had pneumonia diagnoses; the risk was higher in hMPV hospitalizations (RR: 1.17 [1.12–1.23]). 1-year mortality risk was lower in hMPV compared to RSV hospitalizations (HR: 0.84 [0.74–0.94]). The risk of most outcomes, including the occurrence of complications, exacerbation of chronic diseases, in-hospital mortality, and readmission was comparable between hMPV and RSV hospitalizations. Conclusions: Both hMPV and RSV hospitalizations were associated with substantial and similar healthcare resource utilization and morbidity, highlighting the importance of clinical appreciation of severe outcomes associated with hMPV in hospitalized adults.


  • Open Access

    Respiratory Syncytial Virus–associated Acute Otitis Media in Infants and Children

    by Matthew Phillips, Lyn Finelli, Lisa Saiman, Chengbin Wang, Yoonyoung Choi, Janak Patel

    Despite recent declines in the incidence of acute otitis media (AOM), more than 5 million cases and 5–6 million primary AOM visits still occur in young children in the United States, resulting in $4.4 billion direct medical costs annually. Our aims in this review are to describe the role of respiratory syncytial virus (RSV) in the etiology of AOM, discuss the prospect of prevention of RSV-associated AOM through immunization, and suggest future research strategies to assess the impact of immunization on RSV-associated AOM.


  • Open Access

    Viral Loads in Congenital Cytomegalovirus Infection From a Highly Immune Population

    by Aiqiang Xu, Shiwen Wang, Wenqiang Zhang, Xiaofang Wang, Tongzhan Wang, Xiaolin Liu, Haiyan Wang, Wei Ma, Minal Amin, Sheila Dollard, et al.

    Among newborns with congenital cytomegalovirus (CMV) infection from China, there was no difference in CMV viral load in saliva specimens dried and stored at room temperature compared with those kept wet and stored cold, even after longer storage time for the former than the later (74 vs 58 days, P = .02).


  • Open Access

    Urinary Cytomegalovirus Shedding in the United States: The National Health and Nutrition Examination Surveys, 1999–2004

    by Minal M Amin, Stephanie R Bialek, Sheila C Dollard, Chengbin Wang

    There are no data on the prevalence of cytomegalovirus (CMV) shedding from a representative sample of the US population. This information is critical for understanding and preventing CMV. We tested urine specimens from CMV immunoglobulin (Ig) G-positive participants aged 6–49 years in 3 racial/ethnic groups from the National Health and Nutrition Examination Surveys 1999–2004 for the presence of CMV DNA using real-time polymerase chain reaction assay. We examined the association of sociodemographic characteristics with shedding prevalence and viral loads. Among 6828 CMV IgG-positive participants tested, 537 had CMV DNA detected in urine—a shedding prevalence of 9.70%. Among persons aged 6–49 years, shedding prevalence was 3.83%. The prevalence of urinary shedding was inversely associated with increasing age (26.60%, 6.50%, and 3.45% in CMV IgG-positive participants aged 6–11, 12–19, and 20–49 years, respectively; P < .001 for trend test and pairwise comparisons). Urinary viral load also decreased significantly with age (mean, 2.97, 2.69, and 2.43 log10 copies/mL in those age groups, respectively; P < .001 for trend test and pairwise comparisons). Urinary CMV shedding and viral loads decreased dramatically with age, likely reflecting higher rates of primary CMV infection and longer duration of shedding in younger individuals. The findings demonstrate that children aged 6–11 years continue to shed CMV at higher rates and viral loads than adolescents and adults and thus may still be an important source for CMV transmission.


  • Varicella outbreak in a highly-vaccinated school population in Beijing, China during the voluntary two-dose era

    by Luodan Suo, Li Lu, Qinghai Wang, Fan Yang, Xu Wang, Xinghuo Pang, Mona Marin, Chengbin Wang


  • Open Access

    A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China

    by Luodan Suo, Li Lu, Juan Li, Mu Sun, Haihong Wang, Xinhui Peng, Fan Yang, Xinghuo Pang, Mona Marin, Chengbin Wang

    Hospital-based case control studies have found family history of herpes zoster (HZ) was associated with risk of HZ, but the role of family history is not fully examined for other HZ-associated outcomes such as recurrent HZ, occurrence of postherpetic neuralgia (PHN), and HZ with different pain severities. We conducted a population-based matched case control study. HZ cases that occurred during December 1, 2011 to November 30, 2012 were identified by face-to-face interview with all residents of eight selected communities/villages from three districts of Beijing, China. Medical records were reviewed for those who sought healthcare for HZ. For each case-patient, three, age-matched controls (±5 years) without HZ were enrolled from the same community/village of the matched case. Data on family history of HZ were collected by interview and only defined among first-degree relatives. A total of 227 case-patients and 678 matched controls were enrolled. Case-patients were more likely to report a family history of HZ [odds ratio (OR) =2.4, P = 0.002]. Compared with controls, association of family history decreased from HZ with PHN to HZ without PHN (OR = 6.0 and 2.3, respectively; P = 0.002 for trend), from recurrent HZ to primary HZ (OR = 9.4 and 2.2, respectively; P = 0.005 for trend), and from HZ with moderate or severe pain to HZ with mild or no pain (OR = 3.2 and 0.8, respectively; P < 0.001 for trend). Family history of HZ was associated with HZ occurrence and was more likely in HZ case-patients with PHN, recurrences, and painful HZ.


  • Open Access

    Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China

    by Shiwen Wang, Tongzhan Wang, Wenqiang Zhang, Xiaolin Liu, Xiaofang Wang, Haiyan Wang, Xiaozhou He, Shunxian Zhang, Shuhui Xu, Yang Yu, et al.

    Congenital cytomegalovirus (CMV) infection is the leading viral cause of birth defects and developmental disabilities in developed countries. However, CMV seroprevalence and burden of congenital CMV infection are not well defined in China. Cohort of newborns from 5 birthing hospitals in 2 counties of Shandong Province, China, were enrolled from March 2011 to August 2013. Dried blood spots (DBS) and saliva were collected within 4 days after birth for IgG testing for maternal seroprevalence and real-time PCR testing for congenital CMV infection, respectively. Among 5020 newborns tested for CMV IgG, 4827 were seropositive, resulting in CMV maternal seroprevalence of 96.2% (95% confidence interval [CI]:95.6%–96.7%). Of the 10,933 newborns screened for congenital CMV infection, 75 had CMV detected, resulting in an overall prevalence of 0.7% (95% CI: 0.5%–0.9%), with prevalences of 0.4% (14/3995), 0.6% (66/10,857), and 0.7% (52/7761) for DBS, wet saliva, and dried saliva specimens screened, respectively. Prevalence of congenital CMV infection decreased with increasing maternal age (0.9%, 0.6%, and 0.3% among newborns delivered from mothers aged 16–25, 26–35, and >35 years, respectively; P = 0.03), and was higher among preterm infants than full term infants (1.3% vs 0.6%, P = 0.04), infants with intrauterine growth restriction (IUGR) than those without (1.8% vs 0.7%, P = 0.03), and twins or triplets than singleton pregnancies (2.8% vs 0.7%, P = 0.04). None of the 75 newborns exhibited symptomatic congenital CMV infection, and there was no difference in clinical characteristics and newborn hearing screening results between infants with and without congenital CMV infection at birth. Congenital CMV infection prevalence was lower and the clinical manifestations were milder in this relatively developed region of China compared to populations from other countries with similarly high maternal seroprevalence. Follow-up on children with congenital CMV infection will clarify the burden of disabilities from congenital CMV infection in China.


  • Open Access

    Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States

    by Chengbin Wang, Sheila C. Dollard, Minal M. Amin, Stephanie R. Bialek

    Cytomegalovirus (CMV) IgM indicates recent active CMV infection. CMV IgM seroprevalence is a useful marker for prevalence of transmission. Using data from the National Health and Nutrition Examination Survey (NHANES) III 1988–1994, we present estimates of CMV IgM prevalence by race/ethnicity, provide a comparison of IgM seroprevalence among all women and among CMV IgG positive women, and explore factors possibly associated with IgM seroprevalence, including socioeconomic status and exposure to young children. There was no difference in IgM seroprevalence by race/ethnicity among all women (3.1%, 2.2%, and 1.6% for non-Hispanic white, non-Hispanic black and Mexican American, respectively; P = 0.11). CMV IgM seroprevalence decreased significantly with increasing age in non-Hispanic black women (P<0.001 for trend) and marginally among Mexican American women (P = 0.07), while no apparent trend with age was seen in non-Hispanic white women (P = 0.99). Among 4001 IgG+ women, 118 were IgM+, resulting in 4.9% IgM seroprevalence. In IgG+ women, IgM seroprevalence varied significantly by age (5.3%, 7.3%, and 3.7% for women of 12–19, 20–29, and 30–49 years; P = 0.04) and race/ethnicity (6.1%, 2.7%, and 2.0% for non-Hispanic white, non-Hispanic black, and Mexican American; P<0.001). The factors reported associated with IgG seroprevalence were not associated with IgM seroprevalence. The patterns of CMV IgM seroprevalence by age, race/ethnicity, and IgG serostatus may help understanding the epidemiology of congenital CMV infection as a consequence of vertical transmission and are useful for identifying target populations for intervention to reduce CMV transmission.